Suppr超能文献

使用新型双链DNA模板对小牛胸腺RNA聚合酶II进行体外转录的研究。

Studies of in vitro transcription by calf thymus RNA polymerase II using a novel duplex DNA template.

作者信息

Kadesch T R, Chamberlin M J

出版信息

J Biol Chem. 1982 May 10;257(9):5286-95.

PMID:7068686
Abstract

Addition of 10 to 100 oligodeoxycytidylate residues to the 3'-OH termini of T7 bacteriophage DNA produces a highly efficient template for transcription in vitro with purified calf thymus RNA polymerase II. Transcription initiates rapidly and selectively at the oligo (dC) ends of such a template and essentially all of the active RNA polymerase II molecules are then committed to a long period of RNA chain elongation. This allows the direct study of the RNA chain elongation and termination reactions and also permits determination of the concentration of active RNA polymerase II that is present. From 15 to 25% of the RNA polymerase molecules in our current preparations are active in these reactions. RNA chain elongation by calf thymus RNA polymerase II is relatively slow (7 nucleotides/s) even at saturating substrate concentrations. The in vitro elongation process appears to be discontinuous, with elongating polymerase molecules pausing for significant periods at certain sequences along the DNA. There is a low, but measurable frequency of RNA chain termination at some sites; however, the majority of elongating transcripts can grow to large sizes (over 6000 nucleotides). Surprisingly, over 60% of the active calf thymus RNA polymerase II molecules form a long DNA-RNA hybrid during in vitro transcription and displace the nontranscribed DNA from the template to produce a characteristic split end structure. DNA-RNA hybrids are also formed during transcription by RNA polymerase II from duplex DNA templates lacking 3' oligo(dC) tails, which takes place predominantly at single strand breaks or ends. Thus the transcriptional elongation reaction carried out by calf thymus RNA polymerase II in vitro differs in several respects from that which must take place in vivo.

摘要

在T7噬菌体DNA的3'-OH末端添加10到100个寡聚脱氧胞苷酸残基,可产生一种高效的体外转录模板,用于纯化的小牛胸腺RNA聚合酶II。转录在这种模板的寡聚(dC)末端迅速且选择性地起始,然后基本上所有活性RNA聚合酶II分子都进入长时间的RNA链延伸阶段。这使得能够直接研究RNA链延伸和终止反应,还能测定存在的活性RNA聚合酶II的浓度。在我们目前的制剂中,15%到25%的RNA聚合酶分子在这些反应中具有活性。即使在底物浓度饱和的情况下,小牛胸腺RNA聚合酶II的RNA链延伸也相对较慢(7个核苷酸/秒)。体外延伸过程似乎是不连续的,延伸的聚合酶分子会在DNA上的某些序列处显著停顿。在某些位点存在低但可测量的RNA链终止频率;然而,大多数延伸的转录本可以生长到较大尺寸(超过6000个核苷酸)。令人惊讶的是,超过60%的活性小牛胸腺RNA聚合酶II分子在体外转录过程中形成长的DNA-RNA杂交体,并将非转录的DNA从模板上置换下来,产生特征性的裂端结构。在缺乏3'寡聚(dC)尾巴的双链DNA模板的转录过程中,RNA聚合酶II也会形成DNA-RNA杂交体,这主要发生在单链断裂或末端。因此,小牛胸腺RNA聚合酶II在体外进行的转录延伸反应在几个方面与体内必须发生的反应不同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验